Search Articles
TRENTON, N.J. – Providence, R.I., claims Celgene Corp. is illegally preventing introduction of generic forms of the blockbuster cancer drugs Thalidomide and its Revlimid analogue, in a federal antitrust complaint.
Categories /
Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.